BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mark G. Lewis Appointed New CEO at BIOQUAL After John C. Landon Retires


6/5/2013 6:54:54 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BIOQUAL Announces the Retirement of John C. Landon as Chief Executive Officer of BIOQUAL and the Appointment of Mark G. Lewis, BIOQUAL’s President, as Chief Executive Officer

ROCKVILLE, Md.--(BUSINESS WIRE)-- Dr. John C. Landon founded BIOQUAL in 1982. He led BIOQUAL for more than 30 years as President and Chief Executive Officer, and grew BIOQUAL to its current position as a $20M+ life sciences corporation.

Effective June 3, 2013, Dr. Mark G. Lewis, BIOQUAL’s President, was also appointed to succeed Dr. Landon as BIOQUAL’s CEO. BIOQUAL’s Board of Directors had appointed Dr. Lewis as BIOQUAL’s President on November 15, 2010, based in part on the belief that Dr. Lewis would be a strong candidate as a successor CEO. Dr. Landon will also retire as an employee of BIOQUAL on August 14, 2013, but will continue as Chairman of the BIOQUAL Board of Directors.

Dr. Lewis joined BIOQUAL as Senior Scientist in August 2003. He became the Executive Vice President in October 2008, and served in that capacity until he became President in 2010.

Dr. Lewis, 58, received his B.A. (1977) degree from Ohio Wesleyan University and his Masters (1980) and Ph.D. (1983) degrees from Ohio State University, Department of Veterinary Pathology. He performed his post-doctoral studies (1983-1984) in the OSU Department of Pharmacology, and continued at OSU as a Research Associate until 1988. From 1988-1991, he was a Staff Virologist at the Southern Research Institute, Frederick, Maryland. From 1991 to 1998, he was a Principal Scientist for the Henry M. Jackson Foundation, Rockville, Maryland. In 1999, Dr. Lewis rejoined the Southern Research Institute as a Staff Scientist, and in 2002 was appointed Acting Director, Senior Scientist.

Since joining BIOQUAL in 2003, Dr. Lewis has been the primary factor in BIOQUAL’s growth in the area of viral infectious diseases and has attracted to BIOQUAL several new commercial and government clients.

Contact:

BIOQUAL

Mark G. Lewis, Ph.D., CEO

301-251-2801



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

BIOQUAL
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES